Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Y- butyric acid

Other chemicals are agonists such as those that directly affect the y-butyric acid receptor (GABAa) receptor in neurons. Drugs such as barbiturates and benzodiazepines are agonists (activators) for this receptor and cause neuronal inhibition and sedation at therapeutic doses but coma and depression at higher doses. Conversely, antagonists (inhibitors) for this receptor such as the insecticides lindane and cyclodienes and picrotoxin inhibit neurons and may cause tremor and convulsions at toxic doses. [Pg.217]

IBA INDOLE BUTYRIC INDOLE BUTYRIC ACID P-INDOLEBUTYRIC ACID y-gNDOLE-3)-BL TYRIC ACID 3-INDOLEBUTYRIC ACID y-gNDOL-3-YL)BUTYRIC ACID INDOLYL-3-BUTYRIC ACID 3-INDOLYL-Y-BUTYRIC ACID >(3-INDOLYL)BUTYRIC ACID 4-gNDOLYL)BUTYRIC ACID 4-(INDOL-3-YL)BUTYRIC ACID 4-(3-INDOLYL)BUTYRIC ACID JIFFY GROW ROO-TONE... [Pg.768]

Dimethylindole magnesium iodide reacts with chloroacetonitrile in ether to give 3-cyanomethyl-2,3-dimethyIindolenme (234). Majima and Hoshino obtained 3-(2-cyanoethyl)indole (235) by the action of j8-chloropropionitrile on indole magnesium iodide. The reaction was slower with j8-chloropropionitrile than with chloro-aeetonitrile. 3-(3-Cyano-w-propyl)indole (236), required as an intermediate in the synthesis of 3-indolyl-y- -butyric acid, was prepared, but not isolated, by the action of y-chloro-Ji-butyronitrile on indole magnesium iodide. ... [Pg.75]

Direct introduction of a C4-bridge is unsuccessful, because upon acylation of y-butyric acid homoannularly cyclization selectively occurs [68], This is why C4- and C 5-bridges have to be constructed by stepwise ring extension reactions... [Pg.55]

Synonyms. 3-(4-Biphenylylcarbonyl) propionic acid p-p-Phenylbenzoyl propionic acid Diphenyl-4-y-oxo-y-butyric acid 4-(4-Biphenylyl)-4-oxobutyric acid. [Pg.246]

As supplied by the manufacturer, monomeric A/-vinylpyrrolidone is normally inhibited with 0.1% flake sodium hydroxide [24]. This inhibitor may be separated by decantation or filtration. An alternative inhibition system involves the use of gaseous ammonia or organic amines. These inhibitors are said not to interfere with the polymerization process and, in fact, may activate it [25]. This activation by ammonia is not entirely surprising. As will be discussed in Section 3B ( Aqueous Solution Polymerization ), aqueous ammonia has been known as an activator in aqueous systems for many years [1]. Certain impurities which have a distinctly inhibitory effect on the polymerization of A-vinylpyrrolidone are y-butyric acid and y-butyrolactone [26]. [Pg.267]

Posaconazole is white to off-white crystalline powder. Posaconazole is a lipophilic substance with an aqueous solubility of less than 2 pg/mL. Three polymorphic forms of posaconazole have been identified but the three-step synthetic process is controlled to constantly produce form I. Prototype tablet and capsule formulations of posaconazole were abandoned in favour of an oral suspension with superior bioavailability. The ready-to-use oral suspension contains 40 mg/mL which is micronised posaconazole in order to increase its surface area and thus bioavailability. There is at present no parenteral formulation of posaconazole available although a water-soluble ester prodmg (carboxylate ester of posaconazole with y-butyric acid phosphate) has undergone evaluation. [Pg.508]

All the amino-acids of physiological importance are a-amino-acids, e.g. (in addition to the above compounds), alanine or a-amino-propionk acid, CHaCH(NH,)COOH, and leucine or a-amino-Y-dimethyl-rt-butyric acid, (CH,)aCHCH,CH(NHa)COOH, and naturally occurring samples (except glycine) are therefore optically active. [Pg.380]

Butyric acid, 2-amino-4-(4-carboxythiazol-2-yl)-occurrence, 6, 327 Butyric acid, 4-(indol-3-yl)-as plant growth regulator, 1, 191 Butyric acid, y-(3-pyridyl)-y-methylamino-as metabolite... [Pg.572]

Y-(4-Biphenylyl)butyric acid [6057-60-9] M 240.3, m 118 , pKeji-4.8. Crystd from MeOH. [Pg.133]

Boiling-point method, 37 determination of, 58 correction for, 59 / 1 iroinacetanilicle, 152 Bromacetic acid, 8g Broiiiaceiyl bromide, 89 Bromuhenzene, 140 y /-Bromobenz.oic acid, 201 Brouiocresol, 165 / Bromoioluene, 167 Butyric acid, 99... [Pg.353]

Preparation of N-Hydroxysuccinimide Ester of L-(-) y-Benzyloxycarbonylamino-a-Hydroxy-butyric Acid A solution of 10.6 grams (0,042 mol) of L-(-)-7-benzyloxycarbonylamino-o-hydroxybutyric acid and 4.8 grams (0.042 mol) of N-hydroxysuccinimide in 200 ml of... [Pg.58]

In addition to the twenty amino acids commonly found in proteins, two others—selenocysteine and pyrrolysine—are found in some organisms, and more than 700 nonprotein amino acids are also found in nature. y-Amino-butyric acid (GABA), for instance, is found in the brain and acts as a neurotransmitter homocysteine is found in blood and is linked to coronary heart disease and thyroxine is found in the thyroid gland, where it acts as a hormone. [Pg.1020]

Neurotransmitter Transporters. Table 2 SLC6 family transporters for GABA (y-amino butyric acid) and glycine... [Pg.837]

The reaction can be also carried out with butyrolactone leading to y-(dialkyl-phosphono)butyric acid esters [153,154]. [Pg.583]

Gaba-Bx y-Amino butyric acid Beta sp., Opuntia sp. 2,39,45... [Pg.281]

Figure 9 Three-dimensional cationic CITP of (A) blank (B) lysozyme (LYSO), creatinine (CREAT), conalbumin (CAL), y-amino-n-butyric acid (GABA), and ovalbumin (OVA) (C) OVA spiked with CREAT and GABA. Capillary 90 cm (length to the detector, 70 cm) x 75 p i.d. leader 10 mM potassium acetate and acetic acid with 0.3% HPMC, pH 4.75 terminator 10 mM acetic acid sample 10 to 30 mg/ml proteins dissolved in leader without HPMC voltage 20 kV. (From Gebauer, P. and Thormann, W.,. Chromatogr., 558, 423, 1991. With permission.)... Figure 9 Three-dimensional cationic CITP of (A) blank (B) lysozyme (LYSO), creatinine (CREAT), conalbumin (CAL), y-amino-n-butyric acid (GABA), and ovalbumin (OVA) (C) OVA spiked with CREAT and GABA. Capillary 90 cm (length to the detector, 70 cm) x 75 p i.d. leader 10 mM potassium acetate and acetic acid with 0.3% HPMC, pH 4.75 terminator 10 mM acetic acid sample 10 to 30 mg/ml proteins dissolved in leader without HPMC voltage 20 kV. (From Gebauer, P. and Thormann, W.,. Chromatogr., 558, 423, 1991. With permission.)...
Melatonin (ML1A, ML1B) Dopamine (Dl, D2, D4, D5) y-Amino butyric acid (GABAB) Leukotrienes (LTB4, LTC4, LTD4)... [Pg.34]

Butane, 1,4-diiodo-, 30, 33 2-Butanone, 3-acetamido-, 33,1 n-BuTYLACETYLENE, 30, IS tert-Butyl alcohol, 30, 19, 20 32, 20 ierl-Butylbenzene, 32, 91 n-Butyl bromide, 30, 16 tert-Butyl hypochlorite, 32, 20 n-Butyl iodide, 30, 34 Butylketene dimer, 31, 71 -ter -Butylphenyl salicylate, 32, 26 Butyrchloral, 33, IS Butyric acid, a, y-dicyano-o-phenyl-, ethyl ester, 30, 80... [Pg.53]

New analyses of material from the interior of the Orgeuil and Ivona meteorites show the presence of P-alanine, glycine and y-amino-n-butyric acid as the main components (0.6-2.0ppm) traces of other amino acids were also detected. The amino acids were present as racemic mixtures, i.e., d/l = 1, so that an extraterrestrial origin can be assumed (Ehrenfreund et al., 2001). [Pg.70]

Figure 2. Acetic acid homologation (%) acetic acid, propionic acid, (A) butyric acids, and (Y) valeric acids, ( Z ) ethane A, effect of syngas composition (operating conditions acetic acid, 833 mmol Ru(IV) oxide, 4.0 mmol Mel, 40 mmol 220°C 272 atm initial pressure) B, effect of operating pressure (operating conditions acetic acid, 417 mmol Ru(IV) oxide, 2.0 mmol Mel, 20 mmol 220°C constant pressure CO/H2 = 1/1)... Figure 2. Acetic acid homologation (%) acetic acid, propionic acid, (A) butyric acids, and (Y) valeric acids, ( Z ) ethane A, effect of syngas composition (operating conditions acetic acid, 833 mmol Ru(IV) oxide, 4.0 mmol Mel, 40 mmol 220°C 272 atm initial pressure) B, effect of operating pressure (operating conditions acetic acid, 417 mmol Ru(IV) oxide, 2.0 mmol Mel, 20 mmol 220°C constant pressure CO/H2 = 1/1)...
The epilepsies constitute a common, serious neurological disorder in humans, affecting approximately 60 million people worldwide. Well in excess of 40 distinct epileptic syndromes have been identified to date. Current treatment is only symptomatic except in uncommon instances when surgical treatment is possible. While available antiseizure medications target ion channels such as the y-amino-butyric acid (GABA)a receptor and voltage activated sodium (Na+) channels, current research seeks to elucidate the cellular and molecular mechanisms by which a normal brain becomes epileptic. Hopefully, this research will lead to the identification of new targets for which small molecules can be identified and used for prevention or cure of epilepsy. [Pg.629]


See other pages where Y- butyric acid is mentioned: [Pg.237]    [Pg.1244]    [Pg.130]    [Pg.870]    [Pg.236]    [Pg.337]    [Pg.382]    [Pg.456]    [Pg.456]    [Pg.2166]    [Pg.2167]    [Pg.1702]    [Pg.237]    [Pg.1244]    [Pg.130]    [Pg.870]    [Pg.236]    [Pg.337]    [Pg.382]    [Pg.456]    [Pg.456]    [Pg.2166]    [Pg.2167]    [Pg.1702]    [Pg.537]    [Pg.63]    [Pg.94]    [Pg.360]    [Pg.484]    [Pg.37]    [Pg.84]    [Pg.466]    [Pg.100]    [Pg.209]    [Pg.189]    [Pg.573]    [Pg.155]    [Pg.942]   
See also in sourсe #XX -- [ Pg.980 , Pg.995 ]

See also in sourсe #XX -- [ Pg.980 , Pg.995 ]

See also in sourсe #XX -- [ Pg.85 ]




SEARCH



Butyrate/butyric acid

Butyric acid

Butyric acid, y-amidosynthesis

Butyric acid, y-amidosynthesis via aziridines

Y-Amino butyric acid

Y-Amino butyric acid (GABA

Y-amino-n-butyric acid

© 2024 chempedia.info